1. Home
  2. SYRE vs DEC Comparison

SYRE vs DEC Comparison

Compare SYRE & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • DEC
  • Stock Information
  • Founded
  • SYRE 2013
  • DEC 2001
  • Country
  • SYRE United States
  • DEC United States
  • Employees
  • SYRE N/A
  • DEC N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • DEC
  • Sector
  • SYRE Health Care
  • DEC
  • Exchange
  • SYRE Nasdaq
  • DEC Nasdaq
  • Market Cap
  • SYRE 1.1B
  • DEC 884.9M
  • IPO Year
  • SYRE 2016
  • DEC N/A
  • Fundamental
  • Price
  • SYRE $16.26
  • DEC $14.31
  • Analyst Decision
  • SYRE Buy
  • DEC Strong Buy
  • Analyst Count
  • SYRE 5
  • DEC 4
  • Target Price
  • SYRE $55.00
  • DEC $20.75
  • AVG Volume (30 Days)
  • SYRE 545.5K
  • DEC 336.6K
  • Earning Date
  • SYRE 08-06-2025
  • DEC 01-01-0001
  • Dividend Yield
  • SYRE N/A
  • DEC 5.68%
  • EPS Growth
  • SYRE N/A
  • DEC N/A
  • EPS
  • SYRE N/A
  • DEC N/A
  • Revenue
  • SYRE N/A
  • DEC $758,798,000.00
  • Revenue This Year
  • SYRE N/A
  • DEC $124.30
  • Revenue Next Year
  • SYRE N/A
  • DEC $2.00
  • P/E Ratio
  • SYRE N/A
  • DEC N/A
  • Revenue Growth
  • SYRE N/A
  • DEC N/A
  • 52 Week Low
  • SYRE $10.91
  • DEC $10.08
  • 52 Week High
  • SYRE $40.26
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.34
  • DEC 43.77
  • Support Level
  • SYRE $16.43
  • DEC $14.71
  • Resistance Level
  • SYRE $17.70
  • DEC $15.69
  • Average True Range (ATR)
  • SYRE 0.99
  • DEC 0.36
  • MACD
  • SYRE -0.02
  • DEC -0.01
  • Stochastic Oscillator
  • SYRE 37.17
  • DEC 4.48

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: